For decades, getting an accurate eyeglass prescription for kids meant specialized equipment and clinical settings. But new research shows that handheld wavefront autorefractors—specifically PlenOptika’s QuickSee Free and QuickSee Free Pro—are bringing clinical-grade accuracy into schools, outreach programs, and even rural villages.
Across multiple peer-reviewed studies, QuickSee technology has consistently delivered refractions that agree closely with gold-standard methods like cycloplegic retinoscopy or subjective refraction.
In Amazonas, Brazil, researchers compared QuickSee to clinical subjective refraction in children aged 4–7 years. The difference in spherical equivalent was just +0.38 ± 0.60 D, with no clinically meaningful deviation—demonstrating strong agreement and reliability even in preschoolers.
The Gambia school screening study evaluated the QuickSee Free (QSF) in children aged 3–17 years. Agreement with cycloplegic retinoscopy was moderate to high, with the device slightly underestimating spherical equivalents but maintaining specificities up to 95% and AUCs over 0.75 for detecting myopia, astigmatism, and anisometropia.
In plain terms: the device gets very close to what a trained eye doctor would find—fast, objectively, and with minimal fuss.
Studies from U.S. research teams have shown QuickSee’s potential in identifying children at risk for significant vision conditions:
The 2024 Bui et al. study in Ophthalmic & Physiological Optics found that QuickSee’s area under the ROC curve (AUC) for detecting any refractive error was ≥0.92—excellent diagnostic performance. Sensitivity and specificity were 84% and 87% under Orinda criteria, and 94% and 78% under AAPOS guidelines.
The 2025 Bui and Kulp ARVO abstract extended this work, showing QuickSee could detect pre-myopia and early myopia with AUCs of 0.73–0.95, meaning strong discrimination even for low hyperopia in children as young as 3 years.
That level of performance makes QuickSee Free a promising school-based screening tool, especially where full exams aren’t feasible.
The QuickSee Free Pro, evaluated by Hernández et al. (2024), introduced a lighter, monocular form factor with improved usability and optics. Its accuracy was comparable to or better than the inherent variability of subjective refraction itself—an impressive benchmark.
In real-world terms, this means the device’s measurements are as consistent as those you’d get from two experienced clinicians testing the same patient. For pediatric screening programs, that’s transformative—reliable, repeatable, and portable.
Multiple pediatric studies report testability rates of 94–100%, even among children under 6 years old. The open-view design reduces accommodation and anxiety—kids can look at a distant target instead of into a dark tunnel—making measurements quick and natural.
Across continents—from Boston to The Gambia and Brazil—QuickSee Free and QuickSee Free Pro have shown clinical-grade accuracy, high testability, and strong screening performance for detecting refractive errors in children.
For ophthalmologists and optometrists, these results suggest that handheld, wavefront-based autorefraction is no longer a compromise—it’s a practical, evidence-based extension of pediatric eye care into schools and communities.
It can be an indispensable tool for providing children with accurate vision correction at a crucial time in their development…and potentially for getting ahead of emerging challenges like myopia.
References:
Bui et al., Ophthalmic Physiol Opt 2024; Loayza et al., J Pediatr Ophthalmol Strabismus 2024; Chaves Filho et al., Cureus 2024; Hernández et al., Ophthalmic Physiol Opt 2024; Bui et al., ARVO 2025 Abstract.
Are you ready to learn how to use QuickSee Free / Free Pro effectively? Tell us about yourself and your circumstances and we will reach out to arrange a training session with you.
